# Hayrettin Tumani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hayrettin-tumani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,067 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 71 |
| i10-index | 231 |
| Last Known Institution | University Hospital Ulm |
| OpenAlex ID | https://openalex.org/A5021936961 |
| ORCID iD | https://orcid.org/0000-0002-1647-6201 |
| Works | 738 |

## Researcher papers

- [Blood GFAP as an emerging biomarker in brain and spinal cord disorders](https://scholariq.org/papers/blood-gfap-as-an-emerging-biomarker-in-brain-and-spinal-cord-disorders/)
- [Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients](https://scholariq.org/papers/contrasting-disease-patterns-in-seropositive-and-seronegative-neuromyelitis/)
- [Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelitis-optica-spectrum-disorders/)
- [Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelits-optica-spectrum-disorders/)
- [Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)](https://scholariq.org/papers/multiple-sclerosis-therapy-consensus-group-mstcg-position-statement-on-disease/)
- [Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options](https://scholariq.org/papers/tauopathies-with-parkinsonism-clinical-spectrum-neuropathologic-basis-biological/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)

## Researcher university

- [University Hospital Ulm](https://scholariq.org/institutions/university-hospital-ulm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
